Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Artesunate-amodiaquine and artemether-lumefantrine for uncomplicated falciparum malaria in children in Chad
ACTRN12622001476729Phase 4Completed
- Sponsor
- Ministry of Public Health
- Start
- Nov 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of artesunate, amodiaquine, artemether and lumefantrine in malaria and Falciparum malaria (PF) (2 arms), sponsored by Ministry of Public Health. Primary endpoint: PCR-corrected treatment failure proportion. Started Nov 2020; status: completed.
02
Drugs
artesunateamodiaquineartemetherlumefantrine
03
Conditions
malariaFalciparum malaria (PF)
Beyond the preview
Go deeper on ACTRN12622001476729.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12622001476729.